Condensed cyclic compound and organic light-emitting device including the same

US10873034B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10873034-B2
Application numberUS-201715413831-A
CountryUS
Kind codeB2
Filing dateJan 24, 2017
Priority dateFeb 11, 2016
Publication dateDec 22, 2020
Grant dateDec 22, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A condensed cyclic compound represented by Formula 1: Ar 1 -(L 1 ) a1 -Ar 2   Formula 1 wherein, in Formula 1, Ar 1 , Ar 2 , L 1 , and a1 are the same as described in the specification.

First claim

Opening claim text (preview).

What is claimed is: 1. A condensed cyclic compound represented by Formula 1: wherein, in Formulae 1, 2-2, 2-4, 3-12, 3-15, and 3-16, Ar 1 is selected from groups represented by Formulae 2-2 and 2-4; Ar 2 is selected from groups represented by Formulae 3-12, 3-15, and 3-16; L 1 is selected from a substituted or unsubstituted C 6 -C 60 arylene group and a substituted or unsubstituted C 1 -C 60 heteroarylene group; a1 is selected from 1, 2, and 3; X 21 is selected from O, S, C(R 22 )(R 23 ), Si(R 22 )(R 23 ), Ge(R 22 )(R 23 ), and P(═O)(R 22 ); X 31 is selected from O, S, N(R 34 ), C(R 34 )(R 35 ), Si(R 34 )(R 35 ), and Ge(R 34 )(R 35 ); provided that when Ar 1 is Formula 2-4 and Ar 2 is Formula 3-12, when X 21 is S, then X 31 is selected from O, S, C(R 34 )(R 35 ), Si(R 34 )(R 35 ), and Ge(R 34 )(R 35 ); A 21 is selected from a C 5 -C 20 carbocyclic group and a C 4 -C 20 heterocyclic group; Y 21 is selected from a substituted or unsubstituted C 6 -C 60 aryl group and a substituted or unsubstituted C 1 -C 60 heteroaryl group; R 21 to R 23 , R 31a to R 31d , R 32a to R 32d , R 33a to R 33d , R 34 , and R 35 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; b21 is selected from 1, 2, 3, 4, 5, 6, 7, and 8; and * denotes a binding site to a neighboring atom. 2. The condensed cyclic compound of claim 1 , wherein L 1 is selected from a phenylene group, a naphthylene group, a pyridinylene group, a pyrimidinylene group, a pyrazinylene group, a pyridazinylene group, and a triazinylene group; and a phenylene group, a naphthylene group, a pyridinylene group, a pyrimidinylene group, a pyrazinylene group, a pyridazinylene group, and a triazinylene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, and a naphthyl group. 3. The condensed cyclic compound of claim 1 , wherein L 1 is selected from a single bond and groups represented by Formulae 4-1 to 4-15: wherein, in Formulae 4-1 to 4-15, R 41 is selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, and a naphthyl group; b41 is selected from 1, 2, 3, and 4; b42 is selected from 1, 2, 3, 4, 5, and 6; and * and *′ each independently denote a binding site to a neighboring atom. 4. The condensed cyclic compound of claim 1 , wherein a1 is 1. 5. The condensed cyclic compound of claim 1 , wherein (L 1 ) a1 is selected from groups represented by Formulae 5-1 to 5-3: wherein, in Formulae 5-1 to 5-3, * and *′ each independently denote a binding site to a neighboring atom. 6. The condensed cyclic compound of claim 1 , wherein A 21 is selected from a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyridine group, a pyrimidine group, a pyrazine group, a quinoline group, an isoquinoline group, 2,6-naphthyridine group, 1,8-naphthyridine group, 1,5-naphthyridine group, 1,6-naphthyridine group, 1,7-naphthyridine group, 2,7-naphthyridine group, a quinoxaline group, a phthalazine group, a quinazoline group, and a cinnoline group. 7. The condensed cyclic compound of claim 1 , wherein A 21 is selected from a benzene group and a naphthalene group. 8. The condensed cyclic compound of claim 1 , wherein Y 21 is selected from a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an indolyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, and a triazinyl group; and a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, an imidazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an indolyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a furanyl group, a benzofuranyl group, a thiophenyl group, a benzothiophenyl group, and a triazinyl group, each substituted with at least one selected from deuterium, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C

Assignees

Inventors

Classifications

  • C07D519/00Primary

    Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

  • Delayed fluorescence emission · CPC title

  • Polycyclic condensed heteroaromatic hydrocarbons · CPC title

  • containing organic luminescent materials · CPC title

  • non-luminescent particle coatings or suspension media · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10873034B2 cover?
A condensed cyclic compound represented by Formula 1: Ar 1 -(L 1 ) a1 -Ar 2   Formula 1 wherein, in Formula 1, Ar 1 , Ar 2 , L 1 , and a1 are the same as described in the specification.
Who is the assignee on this patent?
Samsung Electronics Co Ltd, Samsung Sdi Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D519/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).